Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

In vitro activity of daptomycin against gram-positive European clinical isolates with defined resistance determinants.

Antimicrobial agents and chemotherapy - 1 Mar 2004

Fluit Ad C, Schmitz Franz-Josef, Verhoef Jan, Milatovic Dana

Abstract excerpt

The in vitro activity of daptomycin against 337 gram-positive European clinical isolates with known resistance genes was determined. The MIC ranges for Staphylococcus aureus, enterococci, pneunococci, and streptococci were 0.03 to 1, 0.25 to 8, 0.12 to 1, and 0.06 to 8 micro g/ml, respectively. For only one streptococcus isolate and seven enterococcus isolates was the MIC 8 micro g/ml.

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Anti-Bacterial Agents
Share to Daptomycin
Share to DNA, Bacterial

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Drug Resistance, Bacterial

Share to Europe

Share to Gram-Positive Bacteria

Share to Gram-Positive Bacterial Infections

Share to Microbial Sensitivity Tests

Source

Open in PubMed Open full text

Identifiers

PMID: 14982796
DOI: 10.1128/AAC.48.3.1007-1011.2004
PMCID: PMC353156

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

In vitro activity of daptomycin against gram-positive European clinical isolates with defined resistance determinants.PMID 14982796Read ↗

Daptomycin activity tested against linezolid-nonsusceptible gram-positive clinical isolates.Semantic proximity Read ↗

Daptomycin Dose-Effect Relationship against Resistant Gram-Positive OrganismsSemantic proximity Read ↗

Characterizing vancomycin-resistant Enterococcus strains with various mechanisms of daptomycin resistance developed in an in vitro pharmacokinetic/pharmacodynamic model.Semantic proximity Read ↗

De Novo Daptomycin-Nonsusceptible Enterococcal InfectionsSemantic proximity Read ↗

Discovery of Highly Active Derivatives of Daptomycin by Assessing the Effect of Amino Acid Substitutions at Positions 8 and 11 on a Daptomycin AnalogueSemantic proximity Read ↗

In vitro activity of daptomycin in combination with β-lactams, gentamicin, rifampin, and tigecycline against daptomycin-nonsusceptible enterococci.Semantic proximity Read ↗

Mechanisms of in-vitro-selected daptomycin-non-susceptibility in Staphylococcus aureus.Semantic proximity Read ↗

In vitro prevention of the emergence of daptomycin resistance in Staphylococcus aureus and enterococci following combination with amoxicillin/clavulanic acid or ampicillin.Semantic proximity Read ↗

Resistance studies with daptomycin.Semantic proximity Read ↗

In vitro activity of daptomycin versus linezolid and vancomycin against gram-positive uropathogens and ampicillin against enterococci, causing complicated urinary tract infections.Semantic proximity Read ↗

Results of the surveillance of Tedizolid activity and resistance program: in vitro susceptibility of gram-positive pathogens collected in 2011 and 2012 from the United States and Europe.Semantic proximity Read ↗

In vitro effect of the presence of human albumin or human serum on the bactericidal activity of daptomycin against strains with the main resistance phenotypes in Gram-positives.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.